Recombinant human activated protein C, drotrecogin alfa (activated): a novel therapy for severe sepsis. | Pharmacotherapy;21(11): 1389-402, 2001 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Recombinant human activated protein C, drotrecogin alfa (activated): a novel therapy for severe sepsis.

Kanji, S; Devlin, J W; Piekos, K A; Racine, E.

Affiliation

Kanji S; Department of Pharmacy Services, Detroit Receiving Hospital and University Health Center, USA.

Pharmacotherapy ; 21(11): 1389-402, 2001 Nov.

Article in En | MEDLINE | ID: mdl-11714212

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Protein C / Sepsis / Fibrinolytic Agents Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Pharmacotherapy Year: 2001 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Protein C / Sepsis / Fibrinolytic Agents Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Pharmacotherapy Year: 2001 Document type: Article Affiliation country: Country of publication: